Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Rios

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Nature Medicine|July 7, 2014
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1Jean de la Croix Ndong, Alexander J Makowski, Sasidhar Uppuganti, et al.
Nature Medicine|April 8, 2015
Corrigendum: Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1Jean de la Croix Ndong, Alexander J Makowski, Sasidhar Uppuganti, et al.
Journal of Pediatric Orthopedics|August 28, 2020
Are Some Randomized Clinical Trials Impossible?Jonathan J Rios, B Stephens Richards, David A Stevenson, et al.
Clinical Trials (London, England)|September 29, 2023
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1Andrea M Gross, Scott R Plotkin, Nelson B Watts, et al.
Human Mutation|June 4, 2021
Biallelic variants in RNU12 cause CDAGS syndromeChao Xing, Mohammed Kanchwala, Jonathan J Rios, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 2014
Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1Nandina Paria, Tae-Joon Cho, In Ho Choi, et al.
Human Molecular Genetics|October 26, 2020
Genetic association and characterization of FSTL5 in isolated clubfootAnas M Khanshour, Yared H Kidane, Julia Kozlitina, et al.
The Journal of Clinical Investigation|February 26, 2026
MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathyAysha Khalid, Kristin Denton, Nandina Paria, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancerKit W Tam, Wei Zhang, Junichi Soh, et al.
Elife|October 31, 2019
<i>SCGN</i> deficiency results in colitis susceptibilityLuis F Sifuentes-Dominguez, Haiying Li, Ernesto Llano, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Nature Medicine|July 7, 2014
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1Jean de la Croix Ndong, Alexander J Makowski, Sasidhar Uppuganti, et al.
Nature Medicine|April 8, 2015
Corrigendum: Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1Jean de la Croix Ndong, Alexander J Makowski, Sasidhar Uppuganti, et al.
Journal of Pediatric Orthopedics|August 28, 2020
Are Some Randomized Clinical Trials Impossible?Jonathan J Rios, B Stephens Richards, David A Stevenson, et al.
Clinical Trials (London, England)|September 29, 2023
Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1Andrea M Gross, Scott R Plotkin, Nelson B Watts, et al.
Human Mutation|June 4, 2021
Biallelic variants in RNU12 cause CDAGS syndromeChao Xing, Mohammed Kanchwala, Jonathan J Rios, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 2014
Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1Nandina Paria, Tae-Joon Cho, In Ho Choi, et al.
Human Molecular Genetics|October 26, 2020
Genetic association and characterization of FSTL5 in isolated clubfootAnas M Khanshour, Yared H Kidane, Julia Kozlitina, et al.
The Journal of Clinical Investigation|February 26, 2026
MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathyAysha Khalid, Kristin Denton, Nandina Paria, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancerKit W Tam, Wei Zhang, Junichi Soh, et al.
Elife|October 31, 2019
<i>SCGN</i> deficiency results in colitis susceptibilityLuis F Sifuentes-Dominguez, Haiying Li, Ernesto Llano, et al.
Pageof 6